암젠

주관 임상 단계 분포

진행 중인 임상

• 3상모집 예정협력· Limited Stage Small-Cell Lung Cancer

  Tarlatamab and Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer

  NCT07637513
• 초기 1상모집 예정협력· Abdominal Aortic Aneurysm

  Mechanistic Clinical Trial of PCSK9 Inhibition for AAA

  NCT06081153
• 1상모집 예정협력· Blinatumomab

  A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia

  NCT07283640
• 2상모집 예정협력· Phase 2 Study

  Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia

  NCT07192237
• 3상모집 예정· Autoimmune Hepatitis

  A Trial of Inebilizumab in Participants With Autoimmune Hepatitis

  NCT07598825
• 2상모집 중· Generalized Myasthenia Gravis

  A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

  NCT06987539
• 2상모집 예정협력· Phase II Clinical Trial

  Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)

  NCT07178912
• 2상모집 예정· Immunoglobulin G4-related Disease

  Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD

  NCT07222553
• 3상모집 예정· Obesity

  Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  NCT07684235
• 3상모집 예정· Obesity

  Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  NCT07684144
• 3상모집 예정· Primary Immune Thrombocytopenia

  A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)

  NCT07700238
• 2/3상모집 예정협력· Granulomatosis With Polyangiitis

  TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis

  NCT07176546
• 2상모집 예정협력· Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)

  Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL

  NCT07301424
• 1상모집 중· Diabetes Mellitus, Type 2

  A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

  NCT07590193
• 3상모집 예정· Philadelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic Leukemia

  A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic Leukaemia

  NCT07223190
• 1/2상모집 예정협력· B-cell Acute Lymphoblastic Leukemia

  A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia

  NCT07313852
• 3상모집 중· Neovascular Age-related Macular Degeneration

  A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

  NCT07614776
• 3상모집 중· Obesity or Overweight

  Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

  NCT07575399
• 2상모집 중· Thyroid Eye Disease

  An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease

  NCT07438405
• 해당없음모집 예정협력· Atherosclerotic Cardiovascular Disease (ASCVD)

  Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)

  NCT07355894